Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Respiratory Volumes and Capacities I01:26

Respiratory Volumes and Capacities I

2.0K
Assessing the respiratory rate and rhythm for a complete minute is crucial for evaluating the breathing pattern. Even a minor increase in the patient's average respiratory rate, by as little as three to five breaths per minute, is an early and vital indicator of respiratory distress. Patients with a respiratory rate exceeding twenty-four breaths per minute require close monitoring to determine the physiological alterations. This careful observation is essential for prompt recognition and...
2.0K
Alterations in Respiration II01:30

Alterations in Respiration II

2.5K
There are numerous types of normal and abnormal respiration. Based on ventilatory movements, breathing patterns are classified as regular, deep, or shallow. Examples include Biot's breathing, Cheyne-Stokes respiration, Kussmaul's breathing, hyperventilation, and hypoventilation. Each pattern is clinically significant and aids in evaluating patients.
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
2.5K
Hyperpnea and Hyperventilation01:25

Hyperpnea and Hyperventilation

4.3K
Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
4.3K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.8K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.8K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

1.3K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.3K
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

830
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
830

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing medication appropriateness in the elderly: a review of available measures.

Drugs & aging·2000
Same author

Vitamin E in the treatment of tardive dyskinesia.

The Annals of pharmacotherapy·1999
Same author

Estrogen for dementia-related aggression in elderly men.

The Annals of pharmacotherapy·1999
Same author

Hyperglycemia associated with olanzapine.

The Journal of clinical psychiatry·1999
Same author

Reliability of drug utilization evaluation as an assessment of medication appropriateness.

The Annals of pharmacotherapy·1997
Same author

Reliability of a modified medication appropriateness index in ambulatory older persons.

The Annals of pharmacotherapy·1997
Same journal

Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.

The Annals of pharmacotherapy·2026
Same journal

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.

The Annals of pharmacotherapy·2026
Same journal

RSVpreF: A Vaccine for the Respiratory Syncytial Virus.

The Annals of pharmacotherapy·2026
Same journal

Severe Acute Hepatitis Induced by Combined Rosuvastatin and Ticagrelor Therapy Post-PCI: The Challenges of Multi-Drug DILI Diagnosis.

The Annals of pharmacotherapy·2026
Same journal

Modified vs Full Lead-in Dose Apixaban and Rivaroxaban for Treatment of Acute Venous Thromboembolism.

The Annals of pharmacotherapy·2026
Same journal

A Comparison of Phenobarbital Dosing Strategies for the Treatment of Alcohol Withdrawal Syndrome.

The Annals of pharmacotherapy·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department
07:52

Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department

Published on: January 29, 2011

15.9K

Hyperventilation associated with quetiapine.

P S Shelton1, F L Barnett, S E Krick

  • 1MEDS Program, Resources for Seniors, Raleigh, NC 27609, USA. pennys@rfsnc.org

The Annals of Pharmacotherapy
|August 5, 2000
PubMed
Summary
This summary is machine-generated.

This case report details hyperventilation in a patient treated with quetiapine. The drug may contribute to respiratory changes, potentially influenced by other medications.

More Related Videos

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

2.5K
Author Spotlight: Standardization and Best Practices for Advancing Lung Imaging Using 129Xe MRI
09:08

Author Spotlight: Standardization and Best Practices for Advancing Lung Imaging Using 129Xe MRI

Published on: November 21, 2023

1.6K

Related Experiment Videos

Last Updated: May 6, 2026

Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department
07:52

Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department

Published on: January 29, 2011

15.9K
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

2.5K
Author Spotlight: Standardization and Best Practices for Advancing Lung Imaging Using 129Xe MRI
09:08

Author Spotlight: Standardization and Best Practices for Advancing Lung Imaging Using 129Xe MRI

Published on: November 21, 2023

1.6K

Area of Science:

  • Psychiatry
  • Pharmacology
  • Respiratory Medicine

Background:

  • Quetiapine is an atypical antipsychotic used for major depression with psychotic features.
  • Serotonin plays a role in central and peripheral respiratory regulation.
  • Drug interactions can affect medication metabolism and patient outcomes.

Observation:

  • A 69-year-old woman developed shortness of breath and hyperventilation after quetiapine treatment.
  • The patient exhibited tachypnea and acute respiratory alkalosis during hospitalization.
  • Increased respiratory rate was noted following quetiapine administration.

Findings:

  • Hyperventilation and acute respiratory alkalosis were associated with quetiapine use.
  • This is the first published case report linking quetiapine to hyperventilation.
  • Concomitant use of metronidazole, a CYP3A4 inhibitor, may have contributed to quetiapine accumulation.

Implications:

  • Clinicians should be aware of potential respiratory side effects of quetiapine.
  • Monitoring respiratory status is crucial in patients receiving quetiapine, especially with interacting medications.
  • Further research is needed to elucidate the mechanism of quetiapine-induced hyperventilation.